PLA2G15
Lysosomal phospholipase A and acyltransferase
Also known as: GXVPLA2, LLPL, LYPLA3, PAG15_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NCC3
- Gene
- PLA2G15
- Ensembl
- ENSG00000103066
- Chromosome
- 16
- Canonical length
- 412 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene hydrolyzes lysophosphatidylcholine to glycerophosphorylcholine and a free fatty acid. This enzyme is present in the plasma and thought to be associated with high-density lipoprotein. A later paper contradicts the function of this gene. It demonstrates that this gene encodes a lysosomal enzyme instead of a lysophospholipase and has both calcium-independent phospholipase A2 and transacylase activities. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
412 residues, UniProt reviewed canonical sequence.
>Q8NCC3|PLA2G15
1 MGLHLRPYRV GLLPDGLLFL LLLLMLLADP ALPAGRHPPV VLVPGDLGNQ LEAKLDKPTV
61 VHYLCSKKTE SYFTIWLNLE LLLPVIIDCW IDNIRLVYNK TSRATQFPDG VDVRVPGFGK
121 TFSLEFLDPS KSSVGSYFHT MVESLVGWGY TRGEDVRGAP YDWRRAPNEN GPYFLALREM
181 IEEMYQLYGG PVVLVAHSMG NMYTLYFLQR QPQAWKDKYI RAFVSLGAPW GGVAKTLRVL
241 ASGDNNRIPV IGPLKIREQQ RSAVSTSWLL PYNYTWSPEK VFVQTPTINY TLRDYRKFFQ
301 DIGFEDGWLM RQDTEGLVEA TMPPGVQLHC LYGTGVPTPD SFYYESFPDR DPKICFGDGD
361 GTVNLKSALQ CQAWQSRQEH QVLLQELPGS EHIEMLANAT TLAYLKRVLL GPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLA2G15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 56 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 56 nTPM
- heart muscle: 33 nTPM
- kidney: 33 nTPM
- placenta: 26 nTPM
- tongue: 21 nTPM
- cerebellum: 21 nTPM
Single-cell type
- hofbauer cells: 205 nCPM
- kupffer cells: 85 nCPM
- microglia: 64 nCPM
- syncytiotrophoblasts: 58 nCPM
- macrophages: 48 nCPM
- proximal tubule cells: 37 nCPM
Immune cell
- non-classical monocyte: 33 nTPM
- intermediate monocyte: 28 nTPM
- classical monocyte: 24 nTPM
- basophil: 20 nTPM
- eosinophil: 16 nTPM
- total PBMC: 15 nTPM
Brain region
- thalamus: 22 nTPM
- white matter: 21 nTPM
- pons: 18 nTPM
- midbrain: 17 nTPM
- hypothalamus: 17 nTPM
- cerebral cortex: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.38
- gnomAD missense Z
- 0.75
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ceramide metabolic process
- diacylglycerol biosynthetic process
- fatty acid catabolic process
- glycerophospholipid metabolic process
- phosphatidylcholine catabolic process
- phosphatidylcholine metabolic process
- phosphatidylethanolamine catabolic process
- phosphatidylglycerol metabolic process
- phosphatidylserine metabolic process
- phospholipid metabolic process
Molecular functions
- acylglycerol O-acyltransferase activity
- calcium-independent phospholipase A2 activity
- O-acyltransferase activity
- phosphatidylcholine lysophospholipase activity
- phospholipase A1 activity
- phospholipid binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLA2G15 as an antibody target. Whether an autoantibody or antibody against PLA2G15 could matter depends on whether native PLA2G15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLA2G15 is annotated as secreted, so native PLA2G15 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PLA2G15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...